Cancer BiologyNature CommunicationsPeer-reviewed
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma
George L. Joun, Emma G. Kempe, Brianna Chen…·Lenka Munoz
This study identifies PRDM9 as a factor promoting survival of drug-tolerant persister cells in glioblastoma through metabolic rewiring and cholesterol biosynthesis.